Answers are grounded in this paper and cite their sources.
Background: The standard treatment for decompensated liver cirrhosis is liver transplantation. However, it has several limitations. Recent animal studies suggest that bone marrow stem cell transplantation can lead to regression of liver fibrosis. The objective of this study was to determine the safety and feasibility of autologous bone marrow-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Methods: In this phase 1 trial, four patients with decompensated liver cirrhosis were included.
No takes yet. Share an insight, caveat, or question.
Alimoghaddam et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: